Glucagon-like peptide-1 receptor agonists and oral contraception: Faculty of Sexual and Reproductive Healthcare statement
Posted 26 Sept 2025
Dr Lisa Devine presents safety findings and key practice points regarding the concurrent use of glucagon-like peptide-1 receptor agonists and oral contraception.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.